U.S. market Closed. Opens in 1 hour 18 minutes

OCUP | Ocuphire Pharma, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312009-12-312008-12-312007-12-312006-12-312005-12-31
Revenue19.05M39.85M589.00KN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A190.61K
Cost of Revenue6.00K4.00K4.00K8.00K3.00K48.21K42.36K32.92K27.50KN/AN/AN/AN/AN/AN/AN/AN/AN/A
Gross Profit19.04M39.85M585.00K-8.00K-3.00K-48.21K-42.36K-32.92K-27.50KN/AN/AN/AN/AN/AN/AN/AN/A190.61K
Operating Expenses29.61M21.62M23.29M9.47M4.19M20.49M17.31M16.38M18.24M13.27M7.51M6.11M15.54M6.20M4.96M4.26M6.38M4.08M
Selling, General & Admin11.95M7.27M8.12M2.82M1.82M7.38M6.60M6.29M6.09M6.25M4.26M2.71M3.55M2.94M2.53M2.73M3.05M2.56M
Research & Development17.65M14.36M15.17M6.65M2.37M13.11M10.72M10.09M12.15M7.02M3.25M3.39M11.99M3.25M2.43M1.53M3.33M1.52M
Other Operating Expenses1.84M-14.00K-157.00K9.00K-68.00KN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Operating Income-10.56M18.23M-22.70M-19.97M-4.19M-20.54M-17.35M-16.41M-18.26M-13.27M-7.98M-6.58M-16.13M-6.47M-5.15M-4.43M-6.72MN/A
Other Expenses / Income589.00K-23.00K-33.99M-4.65M-1.98M6.17M-7.94M7.11M3.88M-5.25M-1.52M352.86K4.79M78.47K240.17K128.12K231.60K-1.63M
Before Tax Income-9.97M18.20M-56.69M-24.62M-6.17M-14.37M-25.29M-9.31M-14.38M-18.52M-9.50M-6.23M-11.34M-6.39M-4.91M-4.30M-6.49M-6.35M
Income Tax Expenses12.00K315.00K-159.00K6.86M1.34M-161.14K2.005.002.00N/AN/AN/AN/AN/AN/AN/AN/A6.35M
Net Income-9.99M17.89M-56.53M-31.48M-7.51M-14.37M-25.29M-9.31M-14.38M-18.52M-9.50M-6.23M-11.34M-6.39M-4.91M-4.30M-6.49M-6.35M
Interest ExpensesN/A9.00K2.00K6.85M1.41MN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A99.65KN/A
Basic Shares Outstanding21.59M19.93M14.85M4.66M711.21K685.74K570.63K453.01K379.98K176.11M128.65M97.14M93.05M61.41M55.86M50.33M48.87M41.98M
Diluted Shares Outstanding21.59M20.60M14.85M4.66M711.21K685.74K570.63K453.01K379.98K176.11M128.65M97.14M93.05M61.41M55.86M50.33M48.87M41.98M
EBITDA-9.97M18.23M-56.69M-19.97M-4.19M-14.32M-25.25M-8.96M-14.36M-13.27M-7.94M-6.54M-16.09M-6.42M-5.10M-4.24M-6.59M-6.06M
EBITDA Margin-52.33%45.75%-9,624.28%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%-3,177.34%
EBIT-9.97M18.21M-56.69M-17.77M-4.76M-14.53M-25.29M-9.31M-14.38M-18.52M-9.50M-6.23M-11.34M-6.39M-4.91M-4.30M-6.39MN/A
EBIT Margin-52.36%45.70%-9,624.96%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312009-12-312008-12-312007-12-312006-12-312005-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙